Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05020665
Title A Study to Assess the Efficacy and Safety of Entospletinib in Combination With Intensive Induction and Consolidation Chemotherapy in Adults With Newly Diagnosed Nucleophosmin 1-mutated Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Kronos Bio
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | ISR | HUN | FRA | ESP | DEU | CZE | CAN | BRA


No variant requirements are available.